Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kelvin Okoth"'
Autor:
Anuradhaa Subramanian, Krishnarajah Nirantharakumar, Sarah Hughes, Puja Myles, Tim Williams, Krishna M. Gokhale, Tom Taverner, Joht Singh Chandan, Kirsty Brown, Nikita Simms-Williams, Anoop D. Shah, Megha Singh, Farah Kidy, Kelvin Okoth, Richard Hotham, Nasir Bashir, Neil Cockburn, Siang Ing Lee, Grace M. Turner, Georgios V. Gkoutos, Olalekan Lee Aiyegbusi, Christel McMullan, Alastair K. Denniston, Elizabeth Sapey, Janet M. Lord, David C. Wraith, Edward Leggett, Clare Iles, Tom Marshall, Malcolm J. Price, Steven Marwaha, Elin Haf Davies, Louise J. Jackson, Karen L. Matthews, Jenny Camaradou, Melanie Calvert, Shamil Haroon
Publikováno v:
Subramanian, A, Nirantharakumar, K, Hughes, S, Myles, P, Williams, T, Gokhale, K M, Taverner, T, Chandan, J S, Brown, K, Simms-Williams, N, Shah, A D, Singh, M, Kidy, F, Okoth, K, Hotham, R, Bashir, N Z, Cockburn, N, Lee, S I, Turner, G M, Gkoutos, G V, Aiyegbusi, O L, McMullan, C, Denniston, A K, Sapey, E, Lord, J M, Wraith, D C, Leggett, E, Iles, C, Marshall, T, Price, M J, Marwaha, S, Davies, E H, Jackson, L J, Matthews, K L, Camaradou, J, Calvert, M & Haroon, S 2022, ' Symptoms and risk factors for long COVID in non-hospitalized adults ', Nature Medicine, vol. 28, no. 8, pp. 1706-1714 . https://doi.org/10.1038/s41591-022-01909-w
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 condition or long COVID. We undertook a retrospective matched cohort study
Autor:
Kelvin Okoth, William Parry Smith, G. Neil Thomas, Krishnarajah Nirantharakumar, Nicola J. Adderley
Publikováno v:
BMC Medicine. 21
Background Female reproductive factors are gaining prominence as factors that enhance cardiovascular disease (CVD) risk; nonetheless, menstrual cycle characteristics are under-recognized as a factor associated with CVD. Additionally, there is limited
Publikováno v:
BMC Women's Health. 23
Introduction To describe the incidence and prevalence of pelvic inflammatory disease (PID) and to estimate the risk of cardiometabolic outcomes among women with PID compared to women without PID. Methods A UK retrospective matched cohort study using